We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Trade representatives from the U.S. and South Korea April 1 successfully concluded months-long negotiations on a fair trade agreement (FTA) that includes provisions to increase access to innovative medicines and medical technologies and lengthen patent exclusivity for original products.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor